These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 24933016)

  • 1. Using information from historical high-throughput screens to predict active compounds.
    Riniker S; Wang Y; Jenkins JL; Landrum GA
    J Chem Inf Model; 2014 Jul; 54(7):1880-91. PubMed ID: 24933016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous classifier fusion for ligand-based virtual screening: or, how decision making by committee can be a good thing.
    Riniker S; Fechner N; Landrum GA
    J Chem Inf Model; 2013 Nov; 53(11):2829-36. PubMed ID: 24171408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rethinking molecular similarity: comparing compounds on the basis of biological activity.
    Petrone PM; Simms B; Nigsch F; Lounkine E; Kutchukian P; Cornett A; Deng Z; Davies JW; Jenkins JL; Glick M
    ACS Chem Biol; 2012 Aug; 7(8):1399-409. PubMed ID: 22594495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal HTS Fingerprint Definitions by Using a Desirability Function and a Genetic Algorithm.
    Cortes Cabrera A; Petrone PM
    J Chem Inf Model; 2018 Mar; 58(3):641-646. PubMed ID: 29425455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Iterative Screening with Stepwise Compound Selection Based on Novartis In-house HTS Data.
    Paricharak S; IJzerman AP; Bender A; Nigsch F
    ACS Chem Biol; 2016 May; 11(5):1255-64. PubMed ID: 26878899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data-Driven Derivation of an "Informer Compound Set" for Improved Selection of Active Compounds in High-Throughput Screening.
    Paricharak S; IJzerman AP; Jenkins JL; Bender A; Nigsch F
    J Chem Inf Model; 2016 Sep; 56(9):1622-30. PubMed ID: 27487177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binary classification of a large collection of environmental chemicals from estrogen receptor assays by quantitative structure-activity relationship and machine learning methods.
    Zang Q; Rotroff DM; Judson RS
    J Chem Inf Model; 2013 Dec; 53(12):3244-61. PubMed ID: 24279462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.
    Sukuru SC; Jenkins JL; Beckwith RE; Scheiber J; Bender A; Mikhailov D; Davies JW; Glick M
    J Biomol Screen; 2009 Jul; 14(6):690-9. PubMed ID: 19531667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public Domain HTS Fingerprints: Design and Evaluation of Compound Bioactivity Profiles from PubChem's Bioassay Repository.
    Helal KY; Maciejewski M; Gregori-Puigjané E; Glick M; Wassermann AM
    J Chem Inf Model; 2016 Feb; 56(2):390-8. PubMed ID: 26898267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational Analysis and In silico Predictive Modeling for Inhibitors of PhoP Regulon in S. typhi on High-Throughput Screening Bioassay Dataset.
    Kaur H; Ahmad M; Scaria V
    Interdiscip Sci; 2016 Mar; 8(1):95-101. PubMed ID: 26298582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPU accelerated support vector machines for mining high-throughput screening data.
    Liao Q; Wang J; Webster Y; Watson IA
    J Chem Inf Model; 2009 Dec; 49(12):2718-25. PubMed ID: 19961205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental design strategy: weak reinforcement leads to increased hit rates and enhanced chemical diversity.
    Maciejewski M; Wassermann AM; Glick M; Lounkine E
    J Chem Inf Model; 2015 May; 55(5):956-62. PubMed ID: 25915687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced HTS hit selection via a local hit rate analysis.
    Posner BA; Xi H; Mills JE
    J Chem Inf Model; 2009 Oct; 49(10):2202-10. PubMed ID: 19795815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictions of BuChE inhibitors using support vector machine and naive Bayesian classification techniques in drug discovery.
    Fang J; Yang R; Gao L; Zhou D; Yang S; Liu AL; Du GH
    J Chem Inf Model; 2013 Nov; 53(11):3009-20. PubMed ID: 24144102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space.
    Koutsoukas A; Paricharak S; Galloway WR; Spring DR; Ijzerman AP; Glen RC; Marcus D; Bender A
    J Chem Inf Model; 2014 Jan; 54(1):230-42. PubMed ID: 24289493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational models for the classification of mPGES-1 inhibitors with fingerprint descriptors.
    Xia Z; Yan A
    Mol Divers; 2017 Aug; 21(3):661-675. PubMed ID: 28484935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of machine learning to improve the results of high-throughput docking against the HIV-1 protease.
    Klon AE; Glick M; Davies JW
    J Chem Inf Comput Sci; 2004; 44(6):2216-24. PubMed ID: 15554692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining structural and bioactivity-based fingerprints improves prediction performance and scaffold hopping capability.
    Laufkötter O; Sturm N; Bajorath J; Chen H; Engkvist O
    J Cheminform; 2019 Aug; 11(1):54. PubMed ID: 31396716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
    Martin E; Mukherjee P; Sullivan D; Jansen J
    J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of frequent-hitter behavior based on historical high-throughput screening data.
    M Nissink JW; Blackburn S
    Future Med Chem; 2014 Jun; 6(10):1113-26. PubMed ID: 25078133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.